Share Stem cell engineering is a distinct field at the intersection of stem cell biology, engineering and regenerative medicine. The understanding of how biophysical and biochemical cues in the cells’ surrounding regulate cell fate and differentiation can be harnessed for the development of novel approaches to modulate stem cell behaviors and leading eventually to their clinical utilization. As stem cell knowledge matures, its appropriate translation to the clinical setting is crucial for success. Thus, in addition to fundamental studies, approaches to monitor stem cell responses, enhance regeneration through material properties, uncover the immunological response during regeneration and the accurate design of clinical trials are all required to unlock the therapeutic potential of stem cells. Confirmed Keynote Speakers Kevin D'Amour, Viacyte, Inc. Jürgen Knoblich, Institute of Molecular Biotechnology (IMBA) Brenda Ogle, University of Minnesota-Twin Cities Session Topics Disease modeling Organoid engineering Endogenous repair and immune engineering 3D printing Computational stem cell biology Clinical applications and challenges Differentiation and morphogenesis Towards regenerative therapies Conference Chairs Nicola Elvassore, University of Padova Stephanie Willerth, University of Victoria Organizing Committee Karen Christman, University of California, San Diego Adam J. Engler, University of California, San Diego Sharon Gerecht, Johns Hopkins University Sanjay Kumar, University of California, Berkeley Song Li, University of California, Los Angeles Matthias Lutolf, Ecole Polytechnique Federale de Lausanne (EPFL) Todd McDevitt, University of California, San Francisco Milica Radisic, University of Toronto Peter Zandstra, The University of British Columbia Featured Speakers Kevin D'Amour Kevin D’Amour, Ph.D. is an expert in stem cell science, an inventor of ViaCyte’s key patents and a co-author of high profile publications in renowned scientific journals. In addition to leading research advances in the stem cell program, Dr. D’Amour is frequently called upon to address the biological aspects of ViaCyte’s technology platform with regulating bodies, such as the US patent office and the FDA. Prior to joining ViaCyte, Dr. D’Amour performed pre-doctoral research with Dr. Fred Gage at The Salk Institute where he studied stem cell plasticity in neural stem cells. His past experience also includes a research position at Gen-Probe, Inc. Dr. D’Amour performed undergraduate studies at the University of New Hampshire and earned his Ph.D. in biology at the UC, San Diego.Read more Juergen Knoblich Juergen Knoblich is the vice director of IMBA, the Institute of Molecular Biotechnology in Vienna, Austria. He obtained his PhD from the Max Planck Institute in Tübingen. After a postdoctoral period in the laboratory of Yuh Nung Jan at UCSF, San Francisco, he joined the Institute of Molecular Pathology (Vienna) as a group leader in 1997. In 2004, he moved to the newly founded IMBA where he became deputy director in 2005. Juergen Knoblich is a member of the Austrian Academy of Sciences and the Academia Europea and has been awarded two advanced grants of the European Research Council. Read more Brenda Ogle Brenda M. Ogle, Ph.D., is an Associate Professor of Biomedical Engineering, University of Minnesota-Twin Cities. The primary goal of the Ogle Laboratory is to research mechanisms by which stem cells contribute to tissues during development and use these insights together with engineering principles to replace damaged systems, especially the cardiovascular system. We are particularly intrigued by spontaneous fusion of stem cells with mature cell types including cardiomyocytes. We have found that cardiac programming can occur in this context and are currently probing the transcriptional...Read more
Kevin D'Amour Kevin D’Amour, Ph.D. is an expert in stem cell science, an inventor of ViaCyte’s key patents and a co-author of high profile publications in renowned scientific journals. In addition to leading research advances in the stem cell program, Dr. D’Amour is frequently called upon to address the biological aspects of ViaCyte’s technology platform with regulating bodies, such as the US patent office and the FDA. Prior to joining ViaCyte, Dr. D’Amour performed pre-doctoral research with Dr. Fred Gage at The Salk Institute where he studied stem cell plasticity in neural stem cells. His past experience also includes a research position at Gen-Probe, Inc. Dr. D’Amour performed undergraduate studies at the University of New Hampshire and earned his Ph.D. in biology at the UC, San Diego.Read more
Juergen Knoblich Juergen Knoblich is the vice director of IMBA, the Institute of Molecular Biotechnology in Vienna, Austria. He obtained his PhD from the Max Planck Institute in Tübingen. After a postdoctoral period in the laboratory of Yuh Nung Jan at UCSF, San Francisco, he joined the Institute of Molecular Pathology (Vienna) as a group leader in 1997. In 2004, he moved to the newly founded IMBA where he became deputy director in 2005. Juergen Knoblich is a member of the Austrian Academy of Sciences and the Academia Europea and has been awarded two advanced grants of the European Research Council. Read more
Brenda Ogle Brenda M. Ogle, Ph.D., is an Associate Professor of Biomedical Engineering, University of Minnesota-Twin Cities. The primary goal of the Ogle Laboratory is to research mechanisms by which stem cells contribute to tissues during development and use these insights together with engineering principles to replace damaged systems, especially the cardiovascular system. We are particularly intrigued by spontaneous fusion of stem cells with mature cell types including cardiomyocytes. We have found that cardiac programming can occur in this context and are currently probing the transcriptional...Read more